Policy & Politics
New Jersey Senate Set to Consider Sterile Syringe Program
June 21, 2012
A Senate panel is expected to vote Thursday on a measure that would expand and make permanent New Jersey's sterile syringe program. The Bloodborne Disease Harm Reduction Act of 2006 is a demonstration program, permitting six cities to operate the needle-exchange programs; Atlantic City, Camden, Jersey City, Newark, and Patterson currently do so. The new legislation would authorize any municipality to operate an NEP, and it would appropriate $95,000 to fund it. The outreach has reduced HIV risks and boosted access to drug treatment and other services without increasing crime or drug use, a 2010 state report showed.
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)